-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626.P1.60 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster I

Symposia: Aggressive Lymphomas: Prospective Therapeutic Trials Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Joseph Maakaron, MD1*, Adam S. Asch, MD2, Leslie L. Popplewell, MD, FACP, MPH3, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil4, Ian W. Flinn, MD PhD5, Nilanjan Ghosh, PhD, MD6*, Colin Keane7*, Matthew Ku, MBBS PhD8, Amitkumar Mehta, MD9, Mark Roschewski, MD10, Carol O'Hear, MD, PhD11*, Xuehan Ren12*, Bertha Villa12*, Indu Lal12*, Sonali M. Smith, MD13 and Ranjana H. Advani, MD14

1University of Minnesota, Minneapolis, MN
2Stephenson Cancer Center Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
3Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
4Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom
5Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
6Levine Cancer Institute, Atrium Health, Charlotte
7Princess Alexandra Hospital, Brisbane, Australia
8St Vincent's Hospital, University of Melbourne, Melbourne, Australia
9Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
10Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
11Gilead Sciences, Foster City, CA
12Gilead Sciences Inc, Foster City, CA
13Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
14Stanford Cancer Institute, Stanford University, Stanford, CA

Grzegorz S. Nowakowski, MD1, Johannes Duell, MD2*, Katerina Kopeckova, MD, PhD3*, Marek Trneny, MD4, Christiane Pott5*, Mouhamad Khouja, MSc5*, John M. Burke, MD6, Maeve Waldron-Lynch, MD, MRCP7*, Steve Wagner, PhD8*, Amitava Mukhopadhyay, PhD8*, Derek Blair, PhD8* and David Belada, MUDr, PhD9*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Bavaria, Germany
3Department of Oncology of the 2nd Faculty of Medicine of Charles University and University Hospital in Motol, Prague, Czech Republic
4Charles University General Hospital, Prague, Czech Republic
5Clinic for Internal Medicine II - Haematology, Oncology, University Clinic Schleswig-Holstein, Kiel, Germany
6US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO
7MorphoSys US, Boston, MA
8MorphoSys AG, Planegg, Germany
94th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic

Douglas A. Stewart, MD1, Lois E. Shepherd2, Jill J. Dudebout, MD3*, Jean-François Larouche, MD4, Neil Chua, MD5*, Tara Baetz, MD6*, Michael Crump7, Mona Shafey, MD8, Nizar Abdel-Samad, MD9, Sue Robinson, MD10*, Isabelle Fleury, MD11, Deborah Marcellus, MD12*, Pamela Skrabek, MD, FRCPC13, Jesse Kelly14*, Annette E. Hay15, Bingshu Chen16* and John Kuruvilla, MD17

1Tom Baker Cancer Centre, Calgary, AB, Canada
2Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada
3Queens University, Kingston, ON, CAN
4Hôpital Enfant-Jésus, Centre Hospitalier Universitaire de Quebec, Quebec City, QC, Canada
5Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
6Queen's University, Kingston, ON, Canada
7Princess Margaret Hospital, Toronto, ON, Canada
8Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
9The Moncton Hospital, Moncton, NB, Canada
10Queen Elizabeth II Health Science Center, Halifax, NS, Canada
11Maisonneuve-Rosemont Hospital, Institute of Hematology, Oncology and Cell Therapy, Montreal University, Montreal, QC, Canada
12Hamilton Regional Cancer Center, Hamilton, ON, CAN
13Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
14Canadian Cancer Trials Group, Kingston, ON, Canada
15Canadian Cancer Trials Group, Cancer Research Institute, Kingston, ON, Canada
16Queen's University, Kingston, ON, CAN
17University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada

Gao Yan, PhD1, Xiaoxiao Wang, MD2*, Bing Bai1*, Xue-Ping Li3*, Suxia Lin4*, Yanxia He1*, Liqin Ping1*, Cheng Huang1*, Jibin Li5*, Jiaying Mao1* and Huiqiang Huang, MD, PhD1

1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
2Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
3lixp1@sysucc.org.cn, Guangzhou, China
4Sun Yat-sen University Cancer Center, Guangzhou, China
5Department of Clinical Research, Sun Yat-sen University Cancer Center, Guanzhou, China

Jia Song1*, Hui Liu2*, Zongjiu Jiao3*, Da Gao4*, Kai Ding1*, Yihao Wang1*, Hong Yu5*, Yuanyuan Shao1*, Huijuan Jiang1*, Shan Gao1*, Lijuan Li1*, Rong Fu2* and Zonghong Shao1

1Department of Hematology, General Hospital of Tianjin Medical University, Tianjin, China
2Department of hematology, Tianjin Medical University General Hospital, Tianjin, China
3Department of Hematology, Xingtai People's Hospital, Xingtai, China
4Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
5Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China

Chelsea C. Pinnix, MD, PhD1, Bouthaina S. Dabaja, MD1*, Jillian R. Gunther, MD, PhD1*, Penny Fang, MD1*, Susan Wu, MD1*, Sairah Ahmed, MD2, Raphael E Steiner, MD3, Ranjit Nair, MD4, Paolo Strati, MD5, Jason Westin, MD6, Luis Fayad, MD5, Swami P. Iyer, MD7, Maria Alma Rodriguez, MD8*, Hun Ju Lee, MD5, Felipe Samaniego, MD5, Dai Chihara, MD5, Preetesh Jain, MBBS, MD, DM, PhD9, Lei Feng, MS10*, Christopher R. Flowers, MD3, Sattva S. Neelapu, MD11 and Loretta J. Nastoupil, MD3

1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX
7UT MDANDERSON, Houston, TX
8MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma and Myeloma, UTMDACC, Houston, TX
10Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Ji Ma, MD1*, Qiang He1*, Ke Lu1* and Liang Wang, MD2*

1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
2Department of Hematology, Shengli Oilfield Central Hospital, Dongying, AL, China

Moshe Levy, MD1*, Carl Gustafson, PhD2*, James Purcell, PhD2*, Kevin J. Freise, PhD, MS2, Wissam Assaily, PhD3*, Deanna Brackman, PhD2*, William R. Henner, MS2*, Michael McDevitt, MD, PhD2 and John Kuruvilla, MD4

1Baylor University Medical Center, Dallas, TX
2AbbVie Inc., North Chicago, IL
3AbbVie Inc., North Chicago
4Princess Margaret Cancer Centre, Toronto, ON, Canada

Jiefei Bai, MD1*, Jiangtao Li1*, Ru Feng, MD1*, Long Qian1*, Jingjing Yin1*, Shuai Zhang2*, Ting Wang1*, Yazi Yang1*, Chunli Zhang1*, Jian Li, MD3 and Hui Liu, MD1*

1Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, China
2Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, AL, China
3Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Huilai Zhang1*, Keshu Zhou2*, Ying Cheng3*, Liling Zhang4*, Haiyan Yang5*, Liqun Zou, MD, PhD6*, Junning Cao, MD7, Huiqiang Huang8, Ye Guo9*, Zhao Wang10, Sha Huang11*, Zhiyu Liang11*, Hui Yao11*, Haiyi Guo11*, Yiqian Fang11* and Hongjie Zhu11*

1Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
2Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
3Jilin Cancer Hospital, Changchun, China
4Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
6West China Hospital, Sichuan University, Chengdu, China
7Fudan University Shanghai Cancer Center, Shanghai, China
8Sun Yat-sen University Cancer Center, Guangzhou, China
9Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
10Beijing Friendship Hospital, Capital Medical University, Beijing, China
11BeiGene (Shanghai) Co., Ltd., Shanghai, China

Elizabeth L. Budde, MD, PhD1, Nancy L. Bartlett2*, Pratyush Giri3*, Stephen J. Schuster4*, Sarit Assouline5, Sung-Soo Yoon, MD, PhD6, Keith Fay7*, Matthew J. Matasar, MD, MS8, Norma C. Gutierrez9*, Paula Marlton, MD10, Martin Dreyling, MD11, Dok Hyun Yoon12*, Georg Hess, MD13*, John Radford, MD, FRCPath, FMedSci14*, Volker Wiebking15, Shen Yin15, Eva Cybulski15*, David C. Turner15*, Huang Huang16*, Mingzhu Zhou17*, Elicia Penuel15*, Michael C. Wei15* and Laurie H. Sehn, MD, MPH18

1Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
3Royal Adelaide Hospital, Adelaide, Australia
4Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
5Jewish General Hospital, McGill University, Montreal, QC, Canada
6Seoul National University Hospital, Seoul, Korea, Republic of (South)
7St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
8Memorial Sloan Kettering Cancer Center, New York, NY
9Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
10Princess Alexandra Hospital and University of Queensland, Brisbane, Australia
11Ludwig-Maximilians-University Hospital Munich, Munich, Germany
12Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
13University Cancer Center Mainz, University Medical School of the Johannes Gutenberg-University, Mainz, Germany
14Christie NHS Foundation Trust, Manchester, United Kingdom
15Genentech, Inc., South San Francisco, CA
16F. Hoffmann-La Roche Ltd., Mississauga, ON, Canada
17F. Hoffmann-La Roche, Shanghai, China
18BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada

Jianai Sun1,2*, Yi Xu2*, Min Yang, M.D.1,3*, Huafeng Wang1,2*, Wenjuan Yu, MD3*, Liangshun You1,2*, Haitao Meng1,2*, Chunmei Yang1,3*, Xinping Zhou1,2*, Li Li1,2*, De Zhou, MD1,2*, Xiujing Ye1,2*, Hong-hu Zhu, M.D., Ph.D.1,2*, Hongyan Tong1,2*, Jie Jin, M.D., Ph.D.1,2 and Wanzhuo Xie1,3*

1Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China, Hangzhou, China
2Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China, Hangzhou, China
3Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Adam J. Olszewski1*, Elizabeth L. Budde, MD, PhD2, Julio Chavez3, Nilanjan Ghosh, PhD, MD4*, Manali Kamdar5*, Izidore S. Lossos, MD3, Catherine Diefenbach6*, Waleed Sabry7*, Kathleen Dorritie8, Ling-Yuh Huw9*, Song Pham10*, Ting Jia10*, Hao Wu9*, Iris To9*, Michael C. Wei9 and Sarit Assouline11

1Brown University, Providence, RI
2Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3University of Miami, Miami, FL
4Atrium Health Levine Cancer Institute, Charlotte, NC
5University of Colorado Cancer Center, Aurora, CO
6Perlmutter Cancer Center at NYU Langone Health, New York, NY
7Saskatoon Cancer Center, Saskatoon, SK, Canada
8UPMC Hillman Cancer Center, Pittsburgh, PA
9Genentech, Inc., South San Francisco, CA
10F. Hoffmann-La Roche Ltd, Basel, Switzerland
11Jewish General Hospital, McGill University, Montreal, QC, Canada

Martine Bagot1*, Youn H. Kim, MD2, Pablo L. Ortiz-Romero3*, Pier Luigi Zinzani, MD, PhD4, Neha Mehta-Shah, MD, MSCI5, Olivier Dereure6*, Marie Beylot-Barry7*, Stéphane Dalle8*, Eric D Jacobsen9, Auris Huen, MD, PharmD10*, Andrea Combalia11*, Maxime Battistella, MD, PhD12*, Alejandro A. Gru, MD13*, Hélène Moins-Teisserenc, MD, PhD14*, Michael S. Khodadoust, MD PhD15, Julien Viotti16*, Christine Paiva16*, Marianna Muller16* and Pierluigi Porcu, MD17

1Department of Dermatology, Hôpital Saint Louis, Université Paris Cité, Inserm U976, Paris, CT, France
2Stanford Cancer Institute, Stanford, CA
3Department of Dermatology, Hospital 12 de Octubre Medical School, University Complutense, Madrid, Spain
4Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
5Division of Oncology, Washington University School of Medicine, St. Louis, MO
6Department of Dermatology, CHU Montpellier, Université Montpellier I, Montpellier, France
7Department of Dermatology, Centre Hospitalier Universitaire de Bordeaux – Hôpital Saint-André, B, Bordeaux, France
8Department of Dermatology, Hospices Civils de Lyon, Pierre Bénite, Lyon, France
9Dana-Farber Cancer Institute, Boston, MA
10Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Dermatology, Hospital Clinic de Barcelona, Barcelona, Spain
12INSERM U1165, Universite Paris 7, AP-HP Hopital Saint Louis, Paris, FRA
13Department of Pathology, University of Virginia, Charlottesville, VA
14Hematology Laboratory, Hopital Saint-Louis, AP-HP, Université Paris Cité, INSERM U976, Paris, France
15Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
16INNATE PHARMA, Marseille, France
17Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA

Hui-Qiang Huang, MD PhD1, Gao Yan, PhD2, Ming Jiang3*, Lihong Liu4*, Qing Xiao5*, Yufu Li, MD6*, Hui Zhou7*, Jianfei Xue8*, Dong Wang9*, Dapeng Xie10*, Honglian Li11* and Peng Wang10*

1Sun Yat-sen University Cancer Center, Guangzhou, China
2Department of Medical Oncology, Sun Yat-Sen University Cancer Center, GuangZhou, China
3West China Hospital of Sichuan University, Sichuan, China
4Department of Hematology, The Fourth Hospital of Hebei Medical University, Hebei, China
5The first affilicated hospital of Chongqing medical unversity, Chongqing, China
6Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
7Department of Lymphoma & Hematology, Hunan Cancer Hospital/The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, China
8CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, China
9CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd, Guangzhou, China
10CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd, Shanghai, China
11lihonglian@cspc.cn, Shijiazhuang, Chile

Siyu Fan1*, Chong Jiang2*, Yue Teng2*, Ang Li3*, Jianxin Chen3* and Jingyan Xu, MD4

1China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China
2Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
3The Key Laboratory of Broadband Wireless Communication and Sensor Network Technology (Ministry of Education), Nanjing, China
4Department of Hematology, Nanjing Drum Tower Hospital, Nanjing, China

Neil Bailey, MSc1*, Tori Braun, BS1*, Megumi Bailey, MSc2*, Tenzin Tsomo, BS1*, Jennie Szeto, BS1*, Sandra Benitez Kruidenier, PA-C1*, Vanessa Dunleavy, ARNP1*, Joanna Fesler, ARNP1*, Gayle Funk, PA-C1*, Sonia Glennie, ARNP1*, Judson Hall, PA-C1*, Julia Parker, ARNP1*, Daniel Egan, MD1*, Raya Mawad, MD3*, Carol A Dean, MPH, BSN, RN, OCN1*, Suzan Sullivan, BSN, RN1*, Chia Lu, MS, RN, OCN, BMTCN1*, Heidi Hohmann, RN, BSN, OCN1*, Jordan Briggs, RN, BSN, OCN1* and Krish Patel, MD4

1Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA
2Center for Blood Disorders and Stem Cellular Therapy, Swedish Cancer Institute, Seattle, WA
3Swedish Center for Blood Disorders and Cellular Therapy, Seattle, WA
4Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle

Zhihua Yao1*, Zheng Yan2*, Shuna Yao3*, Haiying Wang3*, Junfeng Chu3*, Shuang Zhao3*, Jie Ma3*, Bing Wei3*, Jiawen Zheng3*, Quande Lin, PhD4,5*, Zheng Xu6*, Xinyang Zhao, PhD7 and Yanyan Liu8*

1Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, China
2Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
3Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
4Henan Cancer Hospital, Zhengzhou, China
5Henan cancer hospital, Affiliated cancer hospital of Zhengzhou University., Zhengzhou, China
6Xinyang Central Hospital, Xinyang, China
7Department of Biochemistry and Molecular Genetics, University of Alabama At Birmingham, Birmingham, AL
8Affiliated Cancer Hospital of Zhengzhou University, zhengzhou, China

Miao Qing, MD1*, Yongfen Huang1*, Can Chen2*, Lingling Wang1*, Jun Feng1*, Chuanhai Xu1*, Yuexin Cheng1*, Jianming Dong1*, Linlin Zhang1* and Hao Xu1*

1Yancheng First People's Hospital, Yancheng, China
2Xuzhou Medical University, Yancheng, China

Jason Westin, MD1, Adam J. Olszewski2*, Laura Maria Fogliatto3, Won-Seog Kim4*, Ho-Jin Shin5*, Hao Wu6*, Shen Yin6, Song Pham7*, Elicia Penuel6*, Jing Jing6*, Michael C. Wei6* and Elizabeth L. Budde, MD, PhD8

1MD Anderson Cancer Center, Houston, TX
2Brown University, Providence, RI
3Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
4Samsung Medical Center, Seoul, Korea, Republic of (South)
5Pusan National University Hospital, Busan, Korea, Republic of (South)
6Genentech, Inc., South San Francisco, CA
7F. Hoffman-La Roche Ltd., Mississauga, ON, Canada
8Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

*signifies non-member of ASH